Stay updated on IBI310 and Siltilimab in NPC Clinical Trial
Sign up to get notified when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.

Latest updates to the IBI310 and Siltilimab in NPC Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.7.0 was added to the record history, representing an updated version of the study record. The previous revision v3.6.6 was removed from the history, updating the version list.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry v3.6.6 is added to the record history. The previous revision v3.6.5 is removed, updating the study record's version history.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision entry was added updating the page version from v3.6.4 to v3.6.5. This reflects a new release of the study record page on ClinicalTrials.gov.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry v3.6.4 is added and the previous entry v3.6.3 is removed, updating the page's revision history.SummaryDifference0.1%

- Check79 days agoChange DetectedA new platform revision (v3.6.3) was added to the record history, replacing the previous revision (v3.6.0). This update pertains to the page’s versioning metadata rather than study data or participant information.SummaryDifference0.1%

- Check94 days agoChange DetectedThe study record now shows recruitment has ceased for participants. The record version has been updated to v3.6.0, and the previous v3.5.5 revision was removed.SummaryDifference0.4%

Stay in the know with updates to IBI310 and Siltilimab in NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.